New Slides, Lit: PLATO, CHAMPION PCI, PCI PROVE-IT, ZEST-AMI
Learn the latest results from PLATO, CHAMPION PCI, PCI PROVET-IT, and ZEST-AMI!
|
FDA Alert on Clopidogrel and Proton Pump Inhibitors
The FDA is alerting the public to new safety information concerning an interaction between clopidogrel, an anti-clotting medication, and omeprazole, a proton pump inhibitor (PPI) used to reduce stomach acid. New data show that the effectiveness of clopidogrel is reduced when both agents are taken together. For more information and to view the full report, click here.
|
2 Clinician's Challenge Activities Available
Expert Panel Members Christopher P. Cannon, MD, and Matthew J. Price, MD, offer thought-provoking clinical scenarios that affect your daily practice. Earn a total of 1.25 AMA PRA Category 1 Credits™ instantly.
|
Clinical Insights® in Platelet Management
New data on clopidogrel dosing and duration, low-dose aspirin use following PCI, and more. Plus, commentary from Expert Panel Member Steven V. Manoukian, MD.
|
New Interactive Case Study: 1 Patient, 3 ACS, 8 Antithrombotics in 11 Days!
Expert Panel Member Christopher P. Cannon, MD, and Michelle O’Donoghue, MD, manage a patient over the course of 11 days. As the patient experiences three acute coronary syndromes, the cardiologists must place five different stents and continually reassess the patient's antiplatelet regimen. Evaluate alternative therapy options for difficult cases. Earn 0.75 AMA PRA Category 1 Credit™ instantly!
|
Participate in Our Latest Audio Journal Club
Expert Panel Members David J. Schneider, MD, and Steven D. Wiviott, MD, discuss TRITON-TIMI 38. Earn 0.75 AMA PRA Category 1 Credits™ instantly!
|
A Journal Club for Primary Care—Intervention & Prevention: Keeping Current with ACS
Issue 6 now available! The Acute Coronary Syndrome Journal Club summarizes key scientific advances and clinical lessons from the literature and presents commentary and insight from recognized experts in the field who treat patients with ACS.
|